type 1 diabetestype 2 diabetesdiabetes self-managementresearchtechnologyThe purpose of this article is to provide nurse practitioners with an update on the current state of diabetes technology. The update includes information about insulin pumps, also known as continuous subcutaneous insulin infusion and...
A new year brings exciting new developments in diabetes management. For the first time, people in the United States who use Abbott’s world-leading FreeStyle Libre continuous glucose monitoring (CGM) technology to manage their diabetes can experience the therapeutic benefits of an automated insul...
Isaac is suitable for individuals with Type 1 and Type 2 diabetes, pre-diabetes, or those wanting to monitor their metabolic health. Using patented technology from Nanoz, the device detects acetone, a volatile organic compound in breath, to measure glucose levels. Isaac provides real-tim...
Advances in diabetes technology A high frequency of blood glucose monitoring is mandatory to assess the various aspects of glycaemic control described in previous sections of this Review. Initial scepticism accompanied the introduction of self-monitoring blood glucose;80 however, a number of studies then...
Over the last decades, technology has become an essential part of the treatment of type 1 diabetes mellitus. After the discovery of insulin in 1920, the introduction of home blood glucose measurements (HBGM) took half a century [1, 2]. From the 1980s onw
In consequence, the CVOTs have raised expectations that newer glucose-lowering agents should offer advantages that extend beyond glycaemic control and weight management to address complications and comorbidities of type 2 diabetes, particularly cardio-renal diseases. Although large prospective outcome trials...
Else Kroener Fresenius Center for Digital Health (EKFZ), Medical Faculty Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany Laura Žigutytė & Jakob Nikolas Kather Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany Daniel Tr...
Technology updates have allowed for improvements in all aspects of diabetes management, but the goal for overall control remains the same: a hemoglobin A1c of less than 7.5% for children and teens and less than 7% for adults. This goal is shared by the American Diabetes Association and the In...
This review focuses on the current status of diabetes in Malaysia, including epidemiology, complications, lifestyle, and pharmacologic treatments, as well as the use of technologies in its management and the adoption of the World Health Organization chronic care model in primary care clinics. Methods...
This review focuses on the current status of diabetes in Malaysia, including epidemiology, complications, lifestyle, and pharmacologic treatments, as well as the use of technologies in its management and the adoption of the World Health Organization chronic care model in primary care clinics. Methods...